Patents
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
08/2012
08/07/2012US8236965 Benzimidazole derivatives and their use as a medicament
08/07/2012US8236964 Thiazolidine derivatives as orexin receptor antagonists
08/07/2012US8236963 Tricyclic spiro derivatives as CRTH2 modulators
08/07/2012US8236828 Insecticidal compounds
08/07/2012US8236825 Mitotic kinesin inhibitors and methods of use thereof
08/07/2012CA2656915C Human protein tyrosine phosphatase inhibitors and methods of use
08/07/2012CA2568897C Saturated and unsaturated 3-pyridyl-benzocycloalkylmethyl-amines for use in the treatment of pains, depressions and anxiety states
08/07/2012CA2563401C Imidazole derivatives used as tafia inhibitors
08/07/2012CA2548654C Piperidine-amino-benzimidazole derivatives as inhibitors of respiratory syncytial virus replication
08/02/2012WO2012103113A1 Pyrazine and imidazolidine derivatives and their uses to treat hepatitis c
08/02/2012WO2012102583A1 Pharmaceutical composition comprising pyridone derivatives
08/02/2012WO2012102459A1 Novel benzothiazole and benzisothiazole derivatives having 5-ht6 receptor inhibitory activity, preparation method thereof, and pharmaceutical composition containing same
08/02/2012WO2012102387A1 Pyrazole derivative and pest control agent
08/02/2012WO2012102357A1 Bicyclic compound and use thereof for medical purposes
08/02/2012WO2012102255A1 Indole derivative and pharmacologically acceptable salt of same
08/02/2012WO2012102254A1 Indole derivative, and pharmacologically acceptable salt thereof
08/02/2012WO2012101263A1 Il17 and ifn-gamma inhibition for the treatment of autoimmune inflammation
08/02/2012WO2012101013A1 Substituted pyridinyl-pyrimidines and their use as medicaments
08/02/2012WO2012100382A1 Purification method of aztreonam
08/02/2012WO2012076704A3 Pyrazole compounds for controlling invertebrate pests
08/02/2012WO2012075393A3 Activators of proteasomal degradation and uses thereof
08/02/2012WO2012068209A3 Bisthiazole inhibitors of pro-matrix metalloproteinase activation
08/02/2012WO2012030914A8 4-azolylaminoquinazoline derivatives and methods of use thereof
08/02/2012US20120197027 Quinazoline Derivatives as Angiogenesis Inhibitors
08/02/2012US20120197014 Small molecule inhibitors of isoprenylcysteine carboxyl methyltransferase with potential anticancer activity
08/02/2012US20120196906 Substituted Imidazole Derivatives, Compositions, and Methods of Use as PTPase Inhibitors
08/02/2012US20120196891 Heterocyclic compound and its use for control of an arthropod pest
08/02/2012US20120196884 Urea substituted sulphonamide derivatives
08/02/2012US20120196871 Process for the synthesis of 2-aminothiazole compounds as kinase inhibitors
08/02/2012US20120196864 Prophylactic or therapeutic agent for cancer
08/02/2012US20120196862 Il17 and ifn-gamma inhibition for the treatment of autoimmune inflammation
08/02/2012US20120196861 Il17 and ifn-gamma inhibition for the treatment of autoimmune inflammation
08/02/2012US20120196838 Compounds for inflammation and immune-related uses
08/02/2012US20120195857 Hepatitis C Virus Inhibitors
08/02/2012CA2825779A1 Il17 and ifn-gamma inhibition for the treatment of autoimmune inflammation
08/02/2012CA2825172A1 Indole derivative and pharmacologically acceptable salt of same
08/02/2012CA2825134A1 Indole derivative, and pharmacologically acceptable salt thereof
08/02/2012CA2824679A1 Pharmaceutical composition comprising pyridone derivatives
08/01/2012EP2481736A1 Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases
08/01/2012EP2481735A1 Substituted heterocyclic derivatives and compositions and their pharmaceutical use as antibacterials
08/01/2012EP2481729A1 Nintrogen-containing bicyclic heteroaryl compounds for the treatment of RAF protein kinase-mediated diseases
08/01/2012EP2480548A2 Indolizine inhibitors of 5-lipoxygenase
08/01/2012EP2480547A2 Indolizine inhibitors of 5-lipoxygenase
08/01/2012EP2480544A1 Compounds which selectively modulate the cb2 receptor
08/01/2012EP2480543A1 Piperidine and piperazine derivatives as smo antagonists
08/01/2012EP2480537A1 Aminoquinazoline compounds for combating invertebrate pests
08/01/2012EP2480530A1 Alkene oxindole derivatives and their uses to treat obesity, diabetes and hyperlipidemia
08/01/2012EP2480529A1 Indole derivatives as crac modulators
08/01/2012EP2480086A1 Novel dihydropyrimidin-2(1h)-one compounds as s-nitrosoglutathione reductase inhibitors
08/01/2012EP2159224B1 Bromo-phenyl substituted thiazolyl dihydropyrimidines
08/01/2012EP1954288B1 Amidine derivatives and their uses as medicine
08/01/2012EP1932833B1 Nitrogenated heterocyclic compound and pharmaceutical composition comprising the same
08/01/2012EP1856098B1 Pyrazinyl substituted piperazine-piperidines with cxcr3 antagonist activity
08/01/2012EP1708701B1 Modulators of the glucocorticoid receptor, ap-1, and/or nf-kb activity and use thereof
08/01/2012EP1405852B1 Diamine derivatives
08/01/2012CN102625807A 4-substituted pyridin-3-yl-carboxamide compounds and methods of use
08/01/2012CN102625806A Novel organic electroluminescent compounds and organic electroluminescent device using the same
08/01/2012CN102625799A Heterocyclic compounds and their uses
08/01/2012CN102617564A Compound and preparation method thereof
08/01/2012CN102617563A Compound and preparation method thereof
08/01/2012CN102617562A Thiazole derivant and preparation method and use thereof
08/01/2012CN102617441A N-hydroxy ester preparation method
07/2012
07/31/2012US8232401 Useful as an anti-HIV agent that particularly shows an anti-HIV action based on an integrase inhibitory activity; for treatment or prophylaxis of AIDS; for example, 6-(2,3-dichlorobenzyl)-1-(2-hydroxyethyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
07/31/2012US8232302 Thiazoles and oxazoles useful as modulators of ATP-binding cassette transporters
07/31/2012US8232293 Crystalline forms of a potent HCV inhibitor
07/31/2012US8232285 Quinazolinone compounds and methods of use thereof
07/31/2012US8232272 Benzimidazoledihydrothiadiazinone derivatives as fructose-1,6-bisphosphatase inhibitors, and pharmaceutical compositions comprising same
07/31/2012US8231754 Coloring composition, thermal transfer recording ink sheet, thermal transfer recording method, color toner, inkjet ink, color filter, and dye compound
07/31/2012CA2666310C Substituted imidazoles as bombesin receptor subtype-3 modulators
07/31/2012CA2565599C Substituted 2-quinolyl-oxazoles useful as pde4 inhibitors
07/31/2012CA2516186C Pyridine derivatives as fungicidal compounds
07/31/2012CA2503445C Methylene urea derivatives as raf-kinase inhibitors
07/31/2012CA2449999C Compounds and methods for the treatment or prevention of flavivirus infections
07/26/2012WO2012099317A1 Method for imaging zinc activation within a mitochondrion using a two-photon fluorescent probe, and method for manufacturing the two-photon fluorescent probe
07/26/2012WO2012098416A1 Diarylacetylene hydrazide containing tyrosine kinase inhibitors
07/26/2012WO2012098033A1 Azetidine derivatives useful for the treatment of metabolic and inflammatory diseases
07/26/2012WO2011107283A3 Formulations of taurolidine and method for the production thereof
07/26/2012WO2011097946A8 Oxazolidinone compounds containing ring-fused bicyclic ring, preparation method and use thereof
07/26/2012US20120190853 Benzoimidazolyl-pyrazine compounds for inflammation and immune-related uses
07/26/2012US20120190852 Medical composition for treatment or prophylaxis of glaucoma
07/26/2012US20120190845 Fused compounds that inhibit vanilloid receptor subtype 1 (vr1) receptor
07/26/2012US20120190686 Bicyclo[3.2.1]octyl amide derivatives and uses of same
07/26/2012US20120190673 Pyrazole compounds that modulate the activity of cdk, gsk and aurora kinases
07/26/2012US20120190639 Treatment or prophylaxis of proliferative conditions
07/26/2012US20120190543 Pesticidal compositions
07/26/2012US20120189642 Iminothiadiazine dioxide compounds as bace inhibitors, compositions, and their use
07/26/2012US20120189579 Substituted pyrrolidinone as inhibitors of hepatitis c ns5b polymerase, the pharmaceutical composition thereof and their therapeutic use
07/26/2012CA2825367A1 Diarylacetylene hydrazide containing tyrosine kinase inhibitors
07/26/2012CA2824460A1 Azetidine derivatives useful for the treatment of metabolic and inflammatory diseases
07/25/2012EP2479175A1 Compounds and methods for treating dyslipidemia
07/25/2012EP2479173A1 Therapeutic agents useful for treating pain
07/25/2012EP2479168A1 6-Substituted 2,3,4,5-Tetrahydro-1H-Benzo [d]Azepines as 5-HT2C Receptor Agonists
07/25/2012EP2477982A2 Compounds that modulate intracellular calcium
07/25/2012EP2477981A1 Heterocyclic mglu5 antagonists
07/25/2012EP2477979A1 Compounds for organic light emitting diode emissive layers
07/25/2012EP2477498A1 Inhibitors of diacylglycerol acyltransferase
07/25/2012EP2077266B1 2-pyridinecarboxamide derivative having gk-activating activity
07/25/2012EP1891063B1 Bicyclic derivatives as modulators of ion channels
07/25/2012EP1723121B1 1,4-diaryl-dihydropyrimidin-2-ones and their use as human neutrophil elastase inhibitors
07/25/2012EP1270557B1 Ethylenediamine derivatives
1 ... 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 ... 628